[1] |
Jiang Y, Weng RH, Zhang TF, et al. The performance of rapid plasma reagin (RPR) titer in HIV-negative general paresis after neurosyphilis therapy[J]. BMC Infect Dis,2018,18(1):144-149.
|
[2] |
Marra CM. Neurosyphilis[J]. Continuum (Minneap Minn), 2015,21(6):1714-1728.
|
[3] |
高俊华,李务荣,伍文清, 等. 46例神经梅毒临床特征及影像学特点[J/CD]. 中华实验和临床感染病杂志(电子版),2016,10(5):570-574.
|
[4] |
Xiao Y, Tong ML, Liu LL, et al. Novel predictors of neurosyphilis among HIV-negative syphilis patients with neurological symptoms: an observational study[J]. BMC Infect Dis,2017,17(1):310-321.
|
[5] |
魏春波,伦文辉,万钢, 等. 有症状与无症状神经梅毒患者临床及实验室特征的比较[J/CD]. 中华实验和临床感染病杂志(电子版),2013,7(3):391-394.
|
[6] |
廖非,贾国泉,曹莉, 等. HIV阴性神经梅毒18例临床分析[J]. 国际皮肤性病学杂志,2014,40(3):161-163.
|
[7] |
樊尚荣,梁丽芬. 2015年美国疾病控制中心性传播疾病诊断和治疗指南(续)-梅毒的诊断和治疗指南[J]. 中国全科医学,2015,18(27):3260-3264.
|
[8] |
童曼莉,刘莉莉,林丽蓉, 等. 梅毒实验诊断程序研究进展[J]. 中华检验医学杂志,2017,40(11):898-902.
|
[9] |
李炳旻,邹先彪. 2015年英国梅毒管理指南解读[J]. 实用皮肤病学杂志,2016,9(4):253-255.
|
[10] |
Sun JJ, Wang ZY, Shen JY, et al. Serum TRUST titer ≥ 1:16 is a predictor for neurosyphilis among HIV-infected patients with concurrent syphilis and no neurological symptoms[J]. Medicine,2015,94(45):e2023.
|
[11] |
Pialoux G, Vimont S, Moulignier A, et al. Effect of HIV infection on the course of syphilis [J]. AIDS Rev,2008,10(2):85-92.
|
[12] |
Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015[J]. MMWR Recomm Rep,2015,64(3):1-137.
|
[13] |
程明浩,邹先彪. 2014年欧洲梅毒管理指南解读[J]. 中国临床医生杂志,2015,43(8),87-90.
|
[14] |
严有望. 抗体几何平均滴度计算中如何处理抗体阴性者[J]. 微生物学免疫学进展,2000,28(4):98-100.
|
[15] |
蔡胜男,伦文辉. 梅毒实验室检测及结果解读[J]. 中国血液净化,2017,16(10):661-663.
|
[16] |
王娜,张馨月,张吴琼, 等. 神经梅毒诊断与治疗新进展[J]. 中国现代神经疾病杂志,2016,16(7):397-403.
|
[17] |
张耀文,林京京,孙玉冰, 等. 神经梅毒的研究进展[J]. 中风与神经疾病杂志,2015,6(6):575-576.
|
[18] |
程勇,曹敬荣,王培昌. 抗-HIV阴性神经梅毒患者的临床特点与实验室检测分析[J/CD]. 中华实验和临床感染病杂志(电子版),2016,10(6):669-673.
|
[19] |
吴志华,樊翌明. 神经梅毒的研究进展与现状[J]. 中华皮肤科杂志,2004,37(5):313-315.
|
[20] |
朱晓华. 梅毒的实验室检测技术[J/CD]. 中华实验和临床感染病杂志(电子版),2013,7(1):132-133.
|
[21] |
Zhu L, Gu X, Peng RR, et al. Comparison of the cerebrospinal fluid (CSF) toluidine red unheated serum test and the CSF rapid plasma reagin test with the CSF venereal disease research laboratory test for diagnosis of neurosyphilis among HIV-negative syphilis patients in China[J]. J Clin Microbiol,2014,52(3):736-740.
|
[22] |
Castro R, Prieto ES, Aguas MJ, et a1. Evaluation of the Treponema pallidum particle agglutination technique (TP.PA) in the diagnosis of neurosyphilis[J]. J Clin Lab Anal,2006,20(6):233-238.
|
[23] |
陈春晓,蒋荣猛. 神经梅毒临床及实验室诊断相关因素的分析[J/CD]. 中华实验和临床感染病杂志(电子版),2014,8(5):654-657.
|
[24] |
Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: Association with clinical and laboratory features[J]. J Infect Dis,2004,189(3):369-376.
|
[25] |
Xiao Y, Tong ML, Lin LR, et al. Serological response predicts normalization of cerebrospinal fluid abnormalities at six months after treatment in HIV-negative neurosyphilis patients[J]. Sci Rep,2017,7(1):9911-9918.
|
[26] |
陈小红,杨建,史天威, 等. 20例HIV抗体阴性神经梅毒患者的临床分析[J]. 中国艾滋病性病,2007,13(6):560-562.
|